don't know why you think that is so good?DiaSorin (ds for short)...

don't know why you think that is so good?

DiaSorin (ds for short) thinks the world wide Immunoassay market is only Euro 7b. When Mix&Go becomes the gold standard glue in every test globally on a 10% royalty that means only Euro 700m in revenue to ADO.

I suppose if you add the 20% royalty on the Molecular diagnostics market you get another Euro 400m so ADO's revenue becomes Euro 1.1b.

Thats about $A1.45b so NPAT of about $A900m and on a PE of a modest 10x a market cap of around $9b or about $11 per share.

I'll just settle for the fully franked dividend of around $1 per share.







Please appreciate that I am only kidding. I don't seriously expect a dividend above 10c per share.

;)